ADJUST trial (248 JIA pts w/ Uveitis & inactive >6mos, either continued or weaned off adalimumab. ADA weaning res https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg […]
2025 Lancet review https://t.co/Qbwup6QxZK of Osteoarthritis did not mention/endorse Rx w/ platelet rich plasma (PRP) p https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 01/13/2026
QD Clinic: Sjogren’s – Beyond the Dryness tammytilley@gm… Tue, 01/13/2026 – 08:00 General Rheumatology Education/ACR/EULAR Cancer Labs/Biomarkers NP/PA Coverage Sjogrens
NJ Senate (Senate Bill No. 3560) has voted to permite Physician Assistans to enter the Interstate Physician Assistant Li https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Subcutaneous Anifrolumab in SLE jjcush@gmail.com Mon, 01/12/2026 – 19:10
Systematic review of Apremilast in soriasis and Psoriatic Arthritis: 28 RCTs involving 6825 patients. Efficacy ( PASI 7 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
FIBROSCANS in 60 RA pts on #MTX for 5 yrs w/ liver studies. Mean age = 39.5yrs, w/ Dz Dur
DANFLU-2 RCT of 332 438 elderly (43 881 w/ diabetes) tested high (HD-IIV) vs standard dose SD-IIV) flu vaccine. HD-I https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
QD Clinic: Tophi Tales: Management of Uncontrolled Gout Daric Mueller, PA-C and Andrew Sulich, MD, St. Clair Shores, M https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis Lilly announced the topline results from its phase 3b https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
“The practice of medicine is an art, not a trade; a calling, not a business; a calling in which your
Subcutaneous Anifrolumab Effective in Lupus A new study published in Arthritis & Rheumatology demonstrates that su https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sat, 01/10/2026
2025 Rheumatologists, In Memorium In 2025, rheumatology lost many of its most influential clinicians, mentors, and coll https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
DERM on RheumNow Podcast (December 2025) https://t.co/icOauEOhLP https://t.co/eMt40WFiFD https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/09/2026 – 18:30 RheumNow Dr. John Cush DERM on
2026 Resolutions (1.9.2026) jjcush@gmail.com Fri, 01/09/2026 – 18:11 Education/ACR/EULAR Anti-Rheumatic Rx Drug Safety General Rheumatology Gout IL-17 JAK/TYK2 Lupus Novel
2026 Resolutions (1.9.2026) jjcush@gmail.com Fri, 01/09/2026 – 18:06
Plenty of evidence that toxic environmental exposures increase #RA risk. Full read, intelligent report from Stanhope et https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
Shortened Leukocyte telomere length (PBL-TL) is assoc w/ systemic sclerosis–ILD. Study of PBL-TL in 244 SSc vs 314 co https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Glucocorticoid Injections in Knee Osteoarthritis A randomized clinical trial of 60 patients found that glucocorticoid https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/09/2026 –
100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significan https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/09/2026
Assess Reproductive Health in SLE Clinic Visits Systemic Lupus Erythematosus (SLE) mainly affects women of childbearin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/09/2026
QD Clinic: Tophi Tales: Management of Uncontrolled Gout tammytilley@gm… Fri, 01/09/2026 – 08:02 Gout Education/ACR/EULAR General Rheumatology Labs/Biomarkers NP/PA Coverage
J&J announced positive topline results from Phase 2b JASMINE study showing the efficacy of of nipocalimab, FcRn bl https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis jjcush@gmail.com Thu, 01/08/2026 – 18:51
Nordic Registry Study on NSAID use of ~750K, w/ 34-40% under 60 yrs. 48-58% started NSAIDs before Dx of OA.
Lilly announced results from phase 3b TOGETHER PsA trial; 271 obese PsA pts Rx w/ combo of ixekizumab & tirzepatide
CASTLE Phase 1/2a CAR-T cell trial of 24 Tx refractory SLE, SSC, IIM pts w/ MB-CART19.1 (autologous CD19 CAR-T). Good
